Welcome to the DZIF -

the German Center for Infection Research

Research Areas

DZIF is doing research in nine areas:

Community-Acquired Infections at Mucosal Interfaces

Hepatitis

HIV

Infections of the Immunocompromised Host

Healthcare-Associated Infections

Malaria and Neglected Tropical Diseases

Emerging Infections

Novel Antibiotics

Tuberculosis

News

News and Press Releases:

Produced by the National Institute of Allergy and Infectious Diseases (NIAID), this digitally colorized scanning electron microscopic (SEM) image, depicts a large group of orange-colored, rod shaped, Mycobacterium tuberculosis bacteria, which cause tuberculosis (TB) in human beings.
© National Institute of Allergy and Infectious Diseases (NIAID)

New S3 Guideline on Tuberculosis Prevention Among New Migrants Published

Prof. Lange (center) receives the Oskar-Medical-Prize
© Mike Auerbach

Prof. Christoph Lange awarded the 2025 Oskar Medical Prize

Prof. Christoph Lange, Head of the Clinical Tuberculosis Infrastructure at the German Center for Infection Research (DZIF) and Medical Director of the Borstel Research Center, Leibniz Lung Center, has
The GUARDIAN project uses AI to combat antibiotic-resistant bacteria.
© JLU (Generated by AI using ChatGPT)

Kickoff meeting for the GUARDIAN research project in Giessen marks the launch of interdisciplinary collaboration against antibiotic resistance

At the DZIF partner site in Giessen, a ceremonial kickoff meeting marked the launch of the GUARDIAN research project, which is funded with 3.5 million euros by the Federal Ministry of Research
Model of a hepatitis E virus particle
© RUB, Marquard

Promising active substance against hepatitis E identified

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of
Symbolic photo, lab work
© Vic Josh/adobe.stock.com

Innovation in Tuberculosis Treatment: New International Study Launched

The Institute of Infectious Diseases and Tropical Medicine has announced the inclusion of the first study participant in the STEP2C Stage 3 trial. The study is part of the international UNITE4TB
All news

What is the DZIF? Find out more in our

DZIF movie

More than 700 people work at the DZIF with the common goal of translating basic research into clinical practice. The well-being of the patient is our primary focus. Get more insights in our new DZIF film:

Watch the movie
A GIF animation with clips from the DZIF film.

Always up-to-date

Sign up for our quarterly newsletter and our press releases and stay up to date.

Select mailing lists
CAPTCHA
14 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Follow us on:

The DZIF Media Centre

The DZIF in Videos, Pictures and Print.

Find Media Content

Research in Focus

Hamburg - Lübeck - Borstel - Riems

Clinical Tuberculosis Center

The Clinical Tuberculosis Center provides the expertise and infrastructure for the optimization, prevention, diagnosis, and treatment of tuberculosis (TB) as well as for translating research results into clinical practice. The main objectives of the Clinical Tuberculosis Center include coordinating clinical research activities involving the DZIF TB cohort. This cohort includes [...]

Read more
Hannover - Braunschweig | Heidelberg | München | Tübingen

Transplant Cohort

Medical data and biological samples obtained from transplant patients are collected and managed across Germany with the help of the DZIF Transplant Cohort. The data and samples form the basis of scientific studies which investigate the connections between numerous factors influencing an organ’s susceptibility to infection and organ function. By [...]

Read more
Tübingen

New strategies for specific eradication of Staphylococcus aureus

In this project, the scientists develop genetically engineered phage lysins and specific bacteriocins for the elimination of hospital germs such as Staphylococcus aureus, they clarify mechanisms of potential resistance mechanisms, and they analyse whether broad-spectrum or specifically acting agents have a more effective and lasting effect on colonization by [...]

Read more
Hannover - Braunschweig

Preclinical development of Amidochelocardins

The challenge of antibiotic drug development today is the discovery and optimisation of novel bioactive compounds that do not show cross-resistances with clinically applied antibiotics, ideally due to a novel mode of action (MoA) which adresses unexploited microbial targets. In the case of chelocardin, this antibiotic substance was identified several [...]

Read more

Our Partner Sites

Location

Bonn - Köln

Research areas
Contact person
Prof Achim Hörauf: Coordinator of the consortium "Neglected tropical diseases" at DZIF.

Prof. Dr. Achim Hörauf

University Hospital Bonn
Deputy Partner Site Speaker Bonn-Köln
Deputy Coordinator Malaria and Neglected Tropical Diseases
E-Mail Send mail
More about this location
Location

Hannover - Braunschweig

Research areas
Contact person
Silke Hartmann

Dr. Silke Hartmann

Hannover Medical School
Partner Site Manager Hannover - Braunschweig
Project Manager Community-Acquired Infections at Mucosal Interfaces
E-Mail Send mail
More about this location
Location

Hamburg - Lübeck - Borstel - Riems

Research areas
Contact person
Nicole Fischer

Prof. Dr. Nicole Fischer

University Medical Center Hamburg-Eppendorf
Deputy Partner Site Speaker Hamburg-Lübeck-Borstel-Riems
Coordinator Bridging Topic "Diagnostics"
E-Mail Send mail
More about this location
München Tübingen Heidelberg Gießen – Marburg – Langen Bonn – Köln Hannover – Braunschweig Hamburg – Lübeck Borstel – Riems